{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:02:07Z","timestamp":1793037727847,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"am","delay-in-days":275,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["T32CA09168"],"award-info":[{"award-number":["T32CA09168"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["T32CA09168"],"award-info":[{"award-number":["T32CA09168"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ygyno.2024.01.038","type":"journal-article","created":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T18:54:11Z","timestamp":1706727251000},"page":"89-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Calendar-period trends in cervical precancer and cancer diagnoses since the introduction of human papillomavirus and cytology co-testing into routine cervical cancer screening at Kaiser Permanente Northern California"],"prefix":"10.1016","volume":"184","author":[{"given":"Brian","family":"Befano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lorey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Poitras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li C.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan A.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camryn","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Kinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Locke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip E.","family":"Castle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2024.01.038_bb0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1468-0009.2011.00652.x","article-title":"Cervical cancer screening in the United States and the Netherlands: a tale of two countries","volume":"90","author":"Habbema","year":"2012","journal-title":"Milbank Q."},{"key":"10.1016\/j.ygyno.2024.01.038_bb0010","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ypmed.2019.04.010","article-title":"Trends in cervical cancer incidence rates by age, race\/ethnicity, histological subtype, and stage at diagnosis in the United States","volume":"123","author":"Islami","year":"2019","journal-title":"Prev. Med."},{"key":"10.1016\/j.ygyno.2024.01.038_bb0015","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1158\/1055-9965.EPI-05-0231","article-title":"Incidence trends of adenocarcinoma of the cervix in 13 European countries","volume":"14","author":"Bray","year":"2005","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2024.01.038_bb0020","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2024.01.038_bb0025","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","article-title":"Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice","volume":"12","author":"Katki","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2024.01.038_bb0030","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2024.01.038_bb0035","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju153","article-title":"Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test","volume":"106","author":"Gage","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2024.01.038_bb0040","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1200\/JCO.22.01424","article-title":"Racial and ethnic disparities in cervical cancer incidence, survival, and mortality by histologic subtype","volume":"41","author":"Cohen","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2024.01.038_bb0045","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/cncr.20064","article-title":"Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000","volume":"100","author":"Wang","year":"2004","journal-title":"Cancer"},{"issue":"182","key":"10.1016\/j.ygyno.2024.01.038_bb0050","first-page":"e1","article-title":"Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status","volume":"200","author":"Salani","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2024.01.038_bb0055","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/AOG.0000000000003761","article-title":"Diagnosis and management of adenocarcinoma in situ: a society of gynecologic oncology evidence-based review and recommendations","volume":"135","author":"Teoh","year":"2020","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2024.01.038_bb0060","first-page":"645","article-title":"Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix--worldwide","volume":"10","author":"Mathew","year":"2009","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.ygyno.2024.01.038_bb0065","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nature21386","article-title":"Integrated genomic and molecular characterization of cervical cancer","volume":"543","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2024.01.038_bb0070","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/LGT.0000000000000542","article-title":"Risk of recurrence after treatment for cervical intraepithelial neoplasia 3 and adenocarcinoma in situ of the cervix: recurrence of CIN 3 and AIS of cervix","volume":"24","author":"Swift","year":"2020","journal-title":"J. Low. Genit. Tract Dis."},{"key":"10.1016\/j.ygyno.2024.01.038_bb0075","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/1471-0528.14808","article-title":"Risk of persistent or recurrent cervical neoplasia in patients with \u2018pure\u2019 adenocarcinoma-in-situ (AIS) or mixed AIS and high-grade cervical squamous neoplasia (cervical intra-epithelial neoplasia grades 2 and 3 (CIN 2\/3)): a population-based study","volume":"125","author":"Codde","year":"2018","journal-title":"Bjog"},{"key":"10.1016\/j.ygyno.2024.01.038_bb0080","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000261191","article-title":"Dose-related effects of ZnCl2 on dental plaque formation and plaque acidogenicity in vivo","volume":"23","author":"Giertsen","year":"1989","journal-title":"Caries Res."},{"key":"10.1016\/j.ygyno.2024.01.038_bb0085","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/LGT.0b013e318283e2c6","article-title":"Long-term follow-up results from women with cervical adenocarcinoma in situ treated by conization: an experience from a large academic women\u2019s hospital","volume":"17","author":"Li","year":"2013","journal-title":"J. Low. Genit. Tract Dis."},{"key":"10.1016\/j.ygyno.2024.01.038_bb0090","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1097\/LGT.0b013e31828543c5","article-title":"Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management","volume":"17","author":"Katki","year":"2013","journal-title":"J. Low. Genit. Tract Dis."},{"key":"10.1016\/j.ygyno.2024.01.038_bb0095","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ajog.2004.02.065","article-title":"Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse","volume":"191","author":"Pretorius","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"481","key":"10.1016\/j.ygyno.2024.01.038_bb0100","first-page":"e1","article-title":"Detection of cervical cancer and its precursors by endocervical curettage in 13,115 colposcopically guided biopsy examinations","volume":"203","author":"Gage","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2024.01.038_bb0105","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/LGT.0000000000000119","article-title":"Which colposcopies should include endocervical curettage?","volume":"19","author":"Pretorius","year":"2015","journal-title":"J. Low. Genit. Tract Dis."},{"key":"10.1016\/j.ygyno.2024.01.038_bb0110","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/01.AOG.0000270154.69879.09","article-title":"Diagnostic utility of endocervical curettage in women undergoing colposcopy for equivocal or low-grade cytologic abnormalities","volume":"110","author":"Solomon","year":"2007","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2024.01.038_bb0115","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S1470-2045(18)30836-2","article-title":"Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study","volume":"20","author":"Simms","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2024.01.038_bb0120","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/ijc.34242","article-title":"Atypical glandular cells and development of cervical cancer: population-based cohort study","volume":"151","author":"Norman","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2024.01.038_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153184","article-title":"The impact of HPV-specific infection in women diagnosed with atypical glandular cells: results from the HPV-AGC study","volume":"216","author":"Bogani","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ygyno.2024.01.038_bb0130","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/ajcp\/aqaa265","article-title":"High-risk human papillomavirus testing, genotyping, and histopathologic follow-up in women with abnormal glandular cells on papanicolaou tests","volume":"156","author":"Zuo","year":"2021","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2024.01.038_bb0135","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ygyno.2023.05.011","article-title":"The combined finding of HPV 16, 18, or 45 and cytologic atypical glandular cells (AGC) indicates a greatly elevated risk of in situ and invasive cervical adenocarcinoma","volume":"174","author":"Schiffman","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.01.038_bb0140","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/jnci\/djad134","article-title":"A novel HPV\/host DNA methylation-score and detection of cervical adenocarcinoma","volume":"115","author":"Gradissimo","year":"2023","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2024.01.038_bb0145","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S2352-4642(18)30220-7","article-title":"Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study","volume":"2","author":"Silverberg","year":"2018","journal-title":"Lancet Child Adolesc. Health"},{"key":"10.1016\/j.ygyno.2024.01.038_bb0150","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US preventive services task force recommendation statement","volume":"320","author":"Curry","year":"2018","journal-title":"Jama"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824000532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824000532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:58:06Z","timestamp":1777474686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825824000532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":30,"alternative-id":["S0090825824000532"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.01.038","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calendar-period trends in cervical precancer and cancer diagnoses since the introduction of human papillomavirus and cytology co-testing into routine cervical cancer screening at Kaiser Permanente Northern California","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.01.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}